Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered"

J Hepatol. 2021 Oct;75(4):990-992. doi: 10.1016/j.jhep.2021.06.024. Epub 2021 Jun 24.
No abstract available

Keywords: COVID-19; Chemical and Drug Induced Liver Injury; Cholangiopathy; Cholangitis; Cholestasis; Intrahepatic; Ketamine.

Publication types

  • Letter
  • Comment

MeSH terms

  • Bile Duct Diseases*
  • COVID-19*
  • Humans
  • Ketamine* / adverse effects
  • Liver Function Tests
  • SARS-CoV-2

Substances

  • Ketamine